CSI Market
Sign In | Register

Avanos Medical Inc (AVNS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AVNS quarterly Cash Flow →
A period-by-period view of cash flow from Avanos Medical Inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-72.90
Depreciation & amortization38.90
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.20
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total9.30
Share-based Compensation12.60
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Goodwill And Intangible Asset Impairment77.00
Income taxes-10.40
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable30.90
Increase (Decrease) in Accounts Payable, Trade0.60
Increase (Decrease) in Accrued Liabilities-12.90
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.40
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities74.70
Investing Activities
Capital Expenditures-31.60
Sale of Capital Items4.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Deposit Receivedon Pending Transaction-
Paymentsto Acquire Businesses and Investments Net of Cash Acquired-
Acquisition Of Assets And Investments In Businesses-
Proceeds From R H Divestiture Post Closing Settlement-
Payments For Proceeds From Investments In Non Affiliates-5.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses and Interest in Affiliates-28.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-60.60
Financing Activities
Short-term debt Net-25.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-9.40
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-2.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-107.70
Spin Off Cash Distributionto Parent-
Transfers from Transfersto Parent-
Decrease Increasein Parent Companys Net Investment-
Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options-
Proceeds And Excess Tax Benefits From Stock Option Exercises-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents107.70
Payments Credits Of Debt Issuance Costs Net-
Proceeds From Lines Of Credit Net-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-37.00
Effect of exchange rate on cash flow5.00
Discontinued operations0.00
Free Cash Flow47.10
Total Cash Flow-17.90
4 historic quarters locked

Sign in to unlock the full Avanos Medical Inc cash flow history.

Sign In Create Free Account

About Avanos Medical Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: avns-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001606498-26-000004

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License